This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
The authors analyzed 41 consecutive infants less than 1 year of age from Saint-Justine Hospital, Quebec, Canada, (1994–1997) with respiratory syncytial virus (RSV) who required mechanical ventilation (MV). All subjects were previously well and did not have chronic lung disease, immune deficiency, or heart disease. All children were randomized within 24 hours of mechanical ventilation and received either nebulized, normal saline or 16 hours a day of ribavirin, 20mg/ml, with a nebulizer for up to 7 days or until extubated, whichever came first. The patients in each group were of similar age (62 days ± 36 in the Ribavirin group and ± 31 in the placebo …
Individual Login
Institutional Login
You may be able to gain access using your login credentials for your institution. Contact your librarian or administrator if you do not have a username and password.
Log in through your institution
Pay Per Article - You may access this article (from the computer you are currently using) for 2 days for US$25.00
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.
In this issue
Jump to section
Related Articles
Cited By...
- No citing articles found.